0

KN-62

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP127191973-A
CAS127191-97-3
Structure
MDL NumberMFCD00083180
Molecular Weight721.84
InChI KeyRJVLFQBBRSMWHX-DHUJRADRSA-N
Description≥95%, powder
Solubility45% (w/v) aq 2-hydroxypropyl-β-cyclodextrin: 0.93 mg/mL; methanol: 10 mg/mL; DMSO: 12 mg/mL; chloroform: 20 mg/mL
Assay≥95%
Coloryellow
Formpowder
Size0.5MG, 1MG
Storage Conditions−20°C
1

CaMKII Inhibitor KN-62 Blunts Tumor Response to Hypoxia by Inhibiting HIF-1α in Hepatoma Cells

Kyoung-Hwa Lee

Korean J Physiol Pharmacol. 2010 Oct;14(5):331-6.

PMID: 21165333

1

Effect of KN-62, a Selective Inhibitor of Calmodulin-Dependent Kinase II, on Mouse Oocyte Activation

N Inagaki, S Suzuki, H Kitai, N Nakatogawa, N Kuji, K Iwahashi, Y Yoshimura

J Assist Reprod Genet. 1997 Nov;14(10):609-16.

PMID: 9447464

1

KN-62, 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazi Ne, a Specific Inhibitor of Ca2+/calmodulin-dependent Protein Kinase II

H Tokumitsu, T Chijiwa, M Hagiwara, A Mizutani, M Terasawa, H Hidaka

J Biol Chem. 1990 Mar 15;265(8):4315-20.

PMID: 2155222

1

KN-62, a Specific Ca++/calmodulin-dependent Protein Kinase Inhibitor, Reversibly Depresses the Rate of Beating of Cultured Fetal Mouse Cardiac Myocytes

K Okazaki, T Ishikawa, M Inui, M Tada, K Goshima, T Okamoto, H Hidaka

J Pharmacol Exp Ther. 1994 Sep;270(3):1319-24.

PMID: 7932185

1

The Isoquinoline Derivative KN-62 a Potent Antagonist of the P2Z-receptor of Human Lymphocytes

C E Gargett, J S Wiley

Br J Pharmacol. 1997 Apr;120(8):1483-90.

PMID: 9113369

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode